Board of Directors
Calmark's current board of directors is presented below.
Kjersti Berg Marthinsen — Chairman of the Board
Kjersti Berg Marthinsen, born in 1972, board member since 2018 and chairman of the board since 2020. Ms. Berg Martinsen holds an MSc in Strategy from BI Business School in Oslo, Norway. She has worked for several years as a consultant both nationally and internationally with commissions in the areas of strategy, organizational development, and leadership and management. In recent years, she has held various managerial positions with Värmland's County Council in Sweden, with responsibility for planning and following up, developmental support and innovation support among other things, as well as the county council's focus on service design and user involvement. In 2018, Ms. Berg Marthinsen began working at Effect Management Development AB where she is Vice President and partner.
Kjersti Berg Marthinsen, born in 1972, board member since 2018 and chairman of the board since 2020. Ms. Berg Martinsen holds an MSc in Strategy from BI Business School in Oslo, Norway. She has worked for several years as a consultant both nationally and internationally with commissions in the areas of strategy, organizational development, and leadership and management. In recent years, she has held various managerial positions with Värmland's County Council in Sweden, with responsibility for planning and following up, developmental support and innovation support among other things, as well as the county council's focus on service design and user involvement. In 2018, Ms. Berg Marthinsen began working at Effect Management Development AB where she is Vice President and partner.
Mathias Karlsson — Board Member and Co-founder
Mathias Karlsson, born in 1972, Calmark's co-founder and the company's medical advisor, board member since 2016 and chaired the board between 2016 and 2020. Karlsson is a physician and completed his doctoral thesis at Karolinska Institute in Sweden in the field of perinatal asphyxia. His role today is CEO of the company Equalis, a provider of External Quality Assessment (EQA) schemes to help laboratories monitor and improve their quality. Mathias Karlsson is the founder and co-owner of HemCheck Sweden AB.
Mathias Karlsson, born in 1972, Calmark's co-founder and the company's medical advisor, board member since 2016 and chaired the board between 2016 and 2020. Karlsson is a physician and completed his doctoral thesis at Karolinska Institute in Sweden in the field of perinatal asphyxia. His role today is CEO of the company Equalis, a provider of External Quality Assessment (EQA) schemes to help laboratories monitor and improve their quality. Mathias Karlsson is the founder and co-owner of HemCheck Sweden AB.
Anna Karin Edstedt Bonamy — Board Member
Anna Karin Edstedt Bonamy, born in 1974, board member since 2018. Ms. Edstedt Bonamy was awarded a PhD in pediatrics from Karolinska Institute in 2008 and has specialized in pediatric and adolescent medicine since 2009. She worked as a neonatal care physician from 2006 to 2017. During her research, she has, among other things, been the project leader of the Swedish section of a large European research project (EPICE) on the care of premature infants. Since 2014, Ms. Edstedt Bonamy has held the position of Associate Professor in Pediatrics at Karolinska Institute. In 2017, she began working for the e-health company Doctrin, where she is now the CEO.
Anna Karin Edstedt Bonamy, born in 1974, board member since 2018. Ms. Edstedt Bonamy was awarded a PhD in pediatrics from Karolinska Institute in 2008 and has specialized in pediatric and adolescent medicine since 2009. She worked as a neonatal care physician from 2006 to 2017. During her research, she has, among other things, been the project leader of the Swedish section of a large European research project (EPICE) on the care of premature infants. Since 2014, Ms. Edstedt Bonamy has held the position of Associate Professor in Pediatrics at Karolinska Institute. In 2017, she began working for the e-health company Doctrin, where she is now the CEO.
Stefan Blomsterberg — Board Member
Stefan Blomsterberg, born in 1964, board member since 2018. Blomsterberg was trained in the Armed Forces and has worked in educational development and pedagogy, as well as with international arms control. Blomsterberg started working in the medtech industry in 2002, has held managerial positions with Vitrolife AB, Mölnlycke Healthcare AB and Bioeffect AB, and is now the CEO of Medfield Diagnostics AB. Management.
Stefan Blomsterberg, born in 1964, board member since 2018. Blomsterberg was trained in the Armed Forces and has worked in educational development and pedagogy, as well as with international arms control. Blomsterberg started working in the medtech industry in 2002, has held managerial positions with Vitrolife AB, Mölnlycke Healthcare AB and Bioeffect AB, and is now the CEO of Medfield Diagnostics AB. Management.
Management Team
Camilla Arneving – Acting CEO & Marketing Director
Camilla Arneving has worked for Calmark for four years. She has served as Marketing Director since August 2020 and has a broad understanding of Calmark's operations. Camilla holds a graduate in business administration and has over 30 years of experience from leading positions in marketing and communication across a range of industries. In November 2022 Camilla also took on the role as acting CEO.
Camilla Arneving has worked for Calmark for four years. She has served as Marketing Director since August 2020 and has a broad understanding of Calmark's operations. Camilla holds a graduate in business administration and has over 30 years of experience from leading positions in marketing and communication across a range of industries. In November 2022 Camilla also took on the role as acting CEO.
Peter Larsson – Interim CFO
Peter Larsson has more than 30 years’ experience of international CEO and CFO positions, mainly in startup and scaleup companies. Peter holds a Master of Business Administration and is experienced in working with global B2B sales and distribution. Peter is currently Managing Partner and Advisor at Evolvefy and his role at Calmark is interim CFO.
Peter Larsson has more than 30 years’ experience of international CEO and CFO positions, mainly in startup and scaleup companies. Peter holds a Master of Business Administration and is experienced in working with global B2B sales and distribution. Peter is currently Managing Partner and Advisor at Evolvefy and his role at Calmark is interim CFO.
Michael Lundh - Quality Assurance and Regulatory Affairs Director
Michael Lundh, has many years of experience in the medical technology industry, mainly in the areas of product development and quality assurance. Michael has been working for Calmark since spring 2016 on project management and QA/RA matters. Michael holds a master's degree and has worked as a freelance project manager for about 18 years. Since October 2020 his position is Quality Assurance and Regulatory Affairs Director.
Michael Lundh, has many years of experience in the medical technology industry, mainly in the areas of product development and quality assurance. Michael has been working for Calmark since spring 2016 on project management and QA/RA matters. Michael holds a master's degree and has worked as a freelance project manager for about 18 years. Since October 2020 his position is Quality Assurance and Regulatory Affairs Director.
Jim Hansson - Director of Production & Logistics
Jim Hansson is responsible for Calmark's production and logistics and has worked at the Company since October 2020. Jim has a wealth of experience from the field of medical devices, including continuous product development, production adaptation, logistics / distribution as well as purchasing, inventory optimization, supplier assessments and Quality Assurance according to ISO 13485.
Jim Hansson is responsible for Calmark's production and logistics and has worked at the Company since October 2020. Jim has a wealth of experience from the field of medical devices, including continuous product development, production adaptation, logistics / distribution as well as purchasing, inventory optimization, supplier assessments and Quality Assurance according to ISO 13485.
Magdalena Tharaldsen - Director International Business Development
Magdalena Tharaldsen has been working for Calmark since August 2020 and has extensive experience of establishing new sales channels and developing new markets from leading positions in life science companies. Magdalena has worked many years in the diagnostics area and holds a M.Sc. in organic and analytical chemistry.
Magdalena Tharaldsen has been working for Calmark since August 2020 and has extensive experience of establishing new sales channels and developing new markets from leading positions in life science companies. Magdalena has worked many years in the diagnostics area and holds a M.Sc. in organic and analytical chemistry.